Cure My Disease

Don't miss your cure!

 Log in / Sign up

A smarter way to track lung disease? new platform aims to personalize COPD and IPF care

NCT ID NCT07723638

Not yet recruiting Knowledge-focused Sponsor: Fondazione Don Carlo Gnocchi ETS Source: ClinicalTrials.gov ↗

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This study is testing whether an integrated precision medicine platform can improve how doctors diagnose and manage chronic inflammatory lung diseases like COPD and idiopathic pulmonary fibrosis. Researchers will collect blood and saliva samples for biomarker analysis, monitor indoor and outdoor environmental exposures, and use telemedicine to track patients' health in real time. The goal is to see if combining these tools can lead to earlier detection of flare-ups, more personalized treatment, and better outcomes for the 200 adults enrolled.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Integrated precision medicine platform combining multi-omics biomarker profiling, environmental exposure assessment, telemedicine monitoring, and precision inhalation devices
What this could lead to
If successful, this approach could enable earlier and more accurate diagnosis of COPD and IPF, personalized treatment plans, and fewer disease flare-ups.
What could go wrong
This is an early-stage observational study, not a treatment trial. The new diagnostic tools may not prove more effective than current methods, and the results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease combined pulmonary fibrosis-emphysema syndrome idiopathic pulmonary fibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IDIOPATHIC PULMONARY FIBROSIS

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.